Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decrease in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a significant drop in short interest in July. As of July 31st, there was short interest totaling 3,495 shares, a drop of 63.8% from the July 15th total of 9,653 shares. Based on an average daily trading volume, of 15,605 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the stock are sold short.

Arcadia Biosciences Price Performance

Arcadia Biosciences stock traded up $0.05 during mid-day trading on Friday, hitting $0.62. 139,968 shares of the company were exchanged, compared to its average volume of 156,549. Arcadia Biosciences has a 12-month low of $0.50 and a 12-month high of $6.71. The company has a market capitalization of $1.51 million, a P/E ratio of -0.14 and a beta of 0.56. The business’s 50 day simple moving average is $0.72 and its two-hundred day simple moving average is $1.21.

Arcadia Biosciences (NASDAQ:RKDA) last announced its earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($1.53). The firm had revenue of $1.44 million during the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 144.61%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.